Coverage
-
August 07, 2024
After accumulating more than half a billion dollars of deficits over its history, VBI Vaccines, a developer of COVID-19 and hepatitis B vaccines, was unable to avoid bankruptcy court as it sought to consummate a sale of some of its assets.
1 other articles on this case.
View all »